Clinical trial Recruiting at 3 sites Interventional Ages 18 to 60

Effects of Inspiratory Muscle Training and PEP on ventilated restrictive lung disease patients

Official title: Effects of Inspiratory Muscle Training and Positive Expiratory Pressure on Mechanically Ventilated Restrictive Lung Disease Patients

Run by Foundation University Islamabad · NCT07867730 · Data updated 2026-11-12

This study tests whether inspiratory muscle training and positive expiratory pressure devices help strengthen breathing muscles and improve lung function in people with restrictive lung diseases who are on mechanical ventilation.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorFoundation University Islamabad
Academic / other
Locations3 sites (Islamabad and 2 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07867730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-60 with restrictive lung disease admitted to ICU and requiring invasive ventilation for more than 48 hours.

Probably not a fit

Patients with COPD or other obstructive diseases, unstable hemodynamics, or contraindications to the interventions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study investigates whether a combined program of inspiratory muscle training and positive expiratory pressure improves respiratory muscle strength and lung mechanics in mechanically ventilated patients with restrictive lung disease. It will collect physiological and clinical outcomes to see if the interventions improve lung compliance and mobilize secretions. The trial is conducted in Pakistan and follows ethical guidelines for human research. Interventions include inspiratory muscle training and conventional chest physical therapy. Participants are adults with restrictive lung disease in ICU on ventilation for more than 48 hours.

Why it matters

Potential benefit: If successful, the approach could shorten ventilation time and improve recovery by strengthening breathing muscles and aiding secretion clearance.

How similar studies have gone: Prior research suggests potential benefits of IMT and PEP, but data in ventilated RLD patients are limited, making this a relatively novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 18 and 60 years.
* Diagnosed with restrictive lung disease (RLD), including interstitial lung diseases, idiopathic pulmonary fibrosis, chest wall deformities, or neuromuscular diseases.
* Admitted to the ICU and requiring invasive mechanical ventilation for more than 48 hours.
* Glasgow Coma Scale score over 13, inspiratory pressures below -20 cmH2O, oxygen saturation above 90%, tidal volumes exceeding 5ml/kg, respiratory rates under 35 breaths per minute
* Hemodynamically stable at the time of enrolment (as determined by the treating physician).

Exclusion Criteria:

* Pre-existing chronic obstructive pulmonary disease (COPD) or other primary obstructive pathologies.
* Hemodynamic instability (e.g., requiring high-dose vasopressors).
* Active pneumothorax or untreated bronchopleural fistula.
* History of cranial or facial trauma, recent thoracic or abdominal surgery contraindicating the intervention.
* Pre-existing cognitive impairment or inability to comprehend and cooperate with the training protocol.

Where it's running

  • Foundation University College of Physical Therapy Islamabad
    Islamabad, Pakistan
    Recruiting
  • Foundation University College of Physical Therapy Islamabad
    Rawalpindi, Pakistan
    Recruiting
  • Foundation University College of Physical Therapy Islamabad
    Rawalpindi, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.